Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) [Phase 3]
This is a completed Phase 3 study evaluating Vedolizumab in children and teenagers with moderate to severe ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
This clinical trial update reports Phase 3 results for mirikizumab in moderately to severely active ulcerative colitis. The study is current…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial of mirikizumab in moderately to severely active ulcerative colitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases [NA]
This completed clinical trial evaluated the medico-economic impact of therapeutic drug monitoring for anti-TNF-α therapy in inflammatory bow…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants [Phase 1]
Mage Biologics conducted a Phase 1 safety study of an oral biologic in healthy participants; the trial for ulcerative colitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Microplastic Analysis in Pediatric Inflammatory Bowel Disease
A pediatric inflammatory bowel disease study from the Medical University of Gdansk is analyzing microplastics and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Diet Intervention Treatment for Active Ulcerative Colitis [NA]
A clinical trial is evaluating a diet-based intervention for active ulcerative colitis and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis [NA]
Massachusetts General Hospital is conducting a clinical trial to study how dietary therapy affects the gut microbiome in Crohn's disease and…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD) [NA]
This clinical trial update reports a pilot study to evaluate feasibility and impact of a remote adapted physical activity program on quality…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases [NA]
A clinical trial update indicates recruitment is ongoing for a remote monitoring application used in the follow-up of patients with active i…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Comparative Outcomes of Ulcerative Colitis Patients With Mayo Endoscopic Score 1 and Histologic Activity Versus Mayo Endoscopic Score 2
This completed clinical trial evaluates outcomes in ulcerative colitis patients with Mayo Endoscopic Score 1 and histologic activity versus …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Argentine Registry of Crohn's Disease and Ulcerative Colitis
This document provides an update on the Argentine Registry of Crohn's Disease and Ulcerative Colitis, a clinical trial registry focused on i…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease [Phase 3]
A Phase 3 clinical trial evaluating Vedolizumab in children and teenagers with ulcerative colitis or Crohn's disease is currently recruiting…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial investigating the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of BCD-261 in adults with …
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China
A real-world study in China is evaluating the safety and effectiveness of IL-23 inhibitors for inflammatory bowel disease (Crohn's disease a…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease
A clinical study from Peking University First Hospital aims to build and validate a predictive model for the efficacy of different biologics…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis [Phase 4]
A phase 4 dose-ranging trial to evaluate budesonide rectal foam in pediatric patients aged 5-17 with active distal ulcerative colitis; study…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Microbiota and Probiotic Therapy in Ulcerative Colitis Patients
This clinical trial update notes that the microbiota and probiotic therapy study in ulcerative colitis patients has completed.
-
FDA approval · 2025-09-17FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
The FDA approved a supplemental BLA for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited. The action concerns regulatory approval rel…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Risankizumab for Fibrostenotic Crohn's Disease Treatment [Phase 3]
A Phase 3 trial of risankizumab (Skyrizi) for fibrostenotic Crohn's disease is planned, with a not-yet-recruiting status; Crohn's disease an…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis [Phase 4]
Phase 4 clinical trial to evaluate safety, efficacy, and pharmacokinetics of Budesonide Extended-Release Tablets in pediatric patients aged …
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: CP101 for the Treatment of Ulcerative Colitis [Phase 1]
A Phase 1 trial evaluating CP101 for ulcerative colitis is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients [Phase 1]
A Phase 1 clinical trial investigating vitamin D (cholecalciferol) supplementation for inflammatory bowel disease, with enrollment not yet s…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
This is an update on a precision-medicine clinical trial for inflammatory bowel disease at Seoul National University Hospital, enrolling for…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants. [NA]
A clinical trial update from Assistance Publique - Hôpitaux de Paris evaluating determinants of progression and complications in inflammator…